Cressman, S., Karsan, A., Hogge, D., McPherson, E., Bolbocean, C., Regier, D., & Peacock, S. (2016). Economic impact of genomic diagnostics for intermediate‐risk acute myeloid leukaemia. Wiley.
Lua i Stíl Chicago (17ú heag.)Cressman, S., A. Karsan, DE Hogge, E. McPherson, C. Bolbocean, DA Regier, agus SJ Peacock. Economic Impact of Genomic Diagnostics for Intermediate‐risk Acute Myeloid Leukaemia. Wiley, 2016.
Lua MLA (9ú heag.)Cressman, S., et al. Economic Impact of Genomic Diagnostics for Intermediate‐risk Acute Myeloid Leukaemia. Wiley, 2016.
Rabhadh: Seans nach mbeach na luanna seo go hiomlán cruinn i ngach uile chás.